CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review PCI and CABG for Treating Stable Coronary Artery Disease Systemic microvascular dysfunction in microvascular and vasospastic angina Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up Know Diabetes by Heart: A Partnership to Improve Cardiovascular Outcomes in Type 2 Diabetes Mellitus 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization) Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction

Clinical Trial2007 Apr 12;356(15):1503-16.

JOURNAL:N Engl J Med. Article Link

Optimal medical therapy with or without PCI for stable coronary disease

Boden WE, O'Rourke RA, COURAGE Trial Research Group. Keywords: optical medical therapy; PCI; stable coronary disease

FULL TEXT PDF